Cargando…
Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Most chronic liver diseases (CLDs) are characterized by inflammatory processes with aberrant expressions of various pro- and anti-inflammatory mediators in the liver. These mediators are the driving force of many inflammatory liver disorders, which often result in fibrosis, cirrhosis, and liver tumo...
Autores principales: | Liu, Ting, Zhou, Yu, Ko, Kwang Suk, Yang, Heping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609837/ https://www.ncbi.nlm.nih.gov/pubmed/26508814 http://dx.doi.org/10.1155/2015/276850 |
Ejemplares similares
-
Protective Effects of Guava Pulp on Cholestatic Liver Injury
por: Peng, Jian, et al.
Publicado: (2013) -
PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation
por: Yao, Youlin, et al.
Publicado: (2014) -
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
por: Li, Ke, et al.
Publicado: (2020) -
Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases
por: Yang, Zongguo, et al.
Publicado: (2021) -
c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
por: Zheng, Kang, et al.
Publicado: (2017)